You are here

  • Home
  • Online First
  • Tranexamic acid should be avoided for acute gastrointestinal bleeds

Article Text

Article menu

other Versions

Download PDFPDF
DTB select
Tranexamic acid should be avoided for acute gastrointestinal bleeds

Abstract

Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers’ attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.

  • drug-related side effects and adverse reactions
  • healthcare quality
  • access
  • evaluation

http://dx.doi.org/10.1136/dtb.2021.000016

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Overview of The HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020; 395:1927–36.

    • Provenance and peer review Commissioned; internally peer reviewed.